New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C After Pegylated Interferon and Ribavirin Therapy-Reference-Cited by-同舟云学术

New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C After Pegylated Interferon and Ribavirin Therapy

Author:

Hu Ching-Chih¹²,Weng Cheng-Hao²³,Hua Man-Chin⁴,Chang Pei-Hung²⁵,Lin Chih-Lang¹²,Chen Yen-Ting¹,Chien Cheng-Hung¹,Lin Shu-Ting¹,Chien Rong-Nan¹²⁶

Affiliation:

1. Department of Hepatogastroenterology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.

2. College of Medicine, Chang Gung University, Taoyuan, Taiwan.

3. Department of Nephrology and Poison Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.

4. Department of Pediatrics, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.

5. Department of Oncology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.

6. Department of Hepatogastroenterology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

Reference47 articles.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献